Albiflorin improves diabetic retinopathy by mitigating oxidative stress and inflammation via the TLR-4/NF-kB signaling pathway
Toxicology Research · 05.07.2025 · 14 (4)
DOI: 10.1093/toxres/tfaf105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 01.08.2025. Verfasst von Liuyi Xie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Beilun District People's Hospital, Ningbo, Zhejiang Province, 315826, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study was to investigate the effects of Albiflorin (ALB) on oxidative stress and inflammation in diabetic retinopathy (DR) and explore its potential mechanism involving the Toll-like receptor 4 (TLR4)/nuclear factor kappa B (NF-κB) signaling pathway. Human retinal microvascular endothelial cells (HRMECs) were treated with high glucose (HG) and ALB. Cell viability was assessed by MTT assay. Oxidative stress markers and inflammatory cytokines were measured by ELISA. TLR4/NF-κB pathway proteins were analyzed by Western blot. A streptozotocin (STZ)-induced diabetic rat model was established to examine retinal histological changes. Serum metabolic parameters, oxidative stress markers, and inflammatory cytokines were evaluated in the DR model and ALB intervention groups. Results showed that ALB improved HRMEC viability under HG induction and reduced oxidative stress and inflammation. ALB inhibited the TLR4/NF-κB pathway in HG-induced HRMECs. Overexpression of TLR4 partially reversed the protective effects of ALB. In diabetic rats, ALB ameliorated metabolic disorders, improved retinal histological structure, and reduced oxidative stress and inflammation. ALB also suppressed the TLR4/NF-κB signaling pathway in vivo. In conclusion, ALB improves DR by resolving oxidative stress and inflammation through inhibiting the TLR4/NF-κB signaling pathway. These findings suggest ALB as a potential therapeutic agent for DR.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Beilun District People's Hospital, Ningbo, Zhejiang Province, 315826, China.
ORCID-Profile: Yudan Gong
Zitieren
APA
Xie, L., Wang, Y., & Gong, Y. (2025). Albiflorin improves diabetic retinopathy by mitigating oxidative stress and inflammation via the TLR-4/NF-kB signaling pathway. Toxicology Research, 14(4). https://doi.org/10.1093/toxres/tfaf105
Vancouver
Xie L, Wang Y, Gong Y. Albiflorin improves diabetic retinopathy by mitigating oxidative stress and inflammation via the TLR-4/NF-kB signaling pathway. Toxicology Research. 2025;14(4). doi:10.1093/toxres/tfaf105
BibTeX
@article{Xie2025,
author = {Xie, Liuyi and Wang, Yingjun and Gong, Yudan},
title = {Albiflorin improves diabetic retinopathy by mitigating oxidative stress and inflammation via the TLR-4/NF-kB signaling pathway},
journal = {Toxicology Research},
year = {2025},
volume = {14},
number = {4},
doi = {10.1093/toxres/tfaf105}
}
EUVIMED